Promising drug takes on rare nerve disorder in major new trial
Disease control
Not yet recruiting
This study tests a drug called govorestat against a placebo in 155 people aged 16-65 with a rare inherited nerve disease (CMT-SORD) that causes weakness and trouble walking. The goal is to see if the drug improves daily function and walking speed over up to 36 months. Participant…
Phase: PHASE3 • Sponsor: Applied Therapeutics, Inc. • Aim: Disease control
Last updated May 17, 2026 10:28 UTC